# Quantinuum Inc.: financial statements, quarterly

QNT · Nasdaq · CIK 2110105 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qnt.md) · [Financials](/companies/qnt/financials.md) · [Filings](/companies/qnt/filings.md) · [Insiders](/companies/qnt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qnt/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | not reported | [2.1](/filings/0001628280-26-056743.md) | [8.0](/filings/0001628280-26-056743.md) |
| Research and development | $m | not reported | [39.7](/filings/0001628280-26-056743.md) | [367](/filings/0001628280-26-056743.md) |
| Operating income | $m | not reported | [(51.1)](/filings/0001628280-26-056743.md) | [(555)](/filings/0001628280-26-056743.md) |
| Income tax | $m | not reported | [0.0](/filings/0001628280-26-056743.md) | [0.6](/filings/0001628280-26-056743.md) |
| Net income | $m | [(30.5)](/filings/0001628280-26-056743.md) | [(56.9)](/filings/0001628280-26-056743.md) | [(65.4)](/filings/0001628280-26-056743.md) |
| Diluted EPS | $ per share | not reported | not reported | [(1.93)](/filings/0001628280-26-056743.md) |
| Basic EPS | $ per share | not reported | not reported | [(1.93)](/filings/0001628280-26-056743.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [763](/filings/0001628280-26-056743.md) | [2,107](/filings/0001628280-26-056743.md) |
| Current assets | $m | not reported | not reported | not reported | [802](/filings/0001628280-26-056743.md) | [2,149](/filings/0001628280-26-056743.md) |
| Total assets | $m | not reported | not reported | not reported | [1,846](/filings/0001628280-26-056743.md) | [3,230](/filings/0001628280-26-056743.md) |
| Current liabilities | $m | not reported | not reported | not reported | [56.3](/filings/0001628280-26-056743.md) | [139](/filings/0001628280-26-056743.md) |
| Shareholders' equity | $m | [310](/filings/0001628280-26-056743.md) | [305](/filings/0001628280-26-056743.md) | [299](/filings/0001628280-26-056743.md) | [174](/filings/0001628280-26-056743.md) | [413](/filings/0001628280-26-056743.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Shares

| Line item | Unit | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: |
| Diluted shares (weighted) | millions of shares | [33.9](/filings/0001628280-26-056743.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.